NCT06218043

An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population

Name: Clinical Trial NCT06218043
Creator: Wenxing Guo
Keywords: Nutrition, Healthy, Restrict subjects' intake of iodine-containing foods, behavioral, clinical trial, China

An Iodine Balance Study in the Elderly

Wenxing Guo·ClinicalTrials.gov·behavioralRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Nutrition, Healthy
Drug/Device/Intervention: Restrict subjects' intake of iodine-containing foods
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Wenxing Guo
Funder: Tianjin Medical University
Location: Lanzhou,Jinan,Tianjin, China

Timeline & enrollment

Phase: N/A
Start date: Apr 01, 2023
End date: Dec 31, 2025
Enrollment: 30 participants

Primary outcome

Iodine intake,Iodine excretion

Summary

Current Chinese dietary iodine reference intake (DRIs) standards lack direct data on recommended iodine intake (RNI) in the elderly. The elderly have a high prevalence of thyroid diseases. The risk threshold of iodine intake in the elderly is unknown. Identifying the appropriate iodine intake for the elderly to maintain optimal thyroid function to reduce the burden on medical resources is a public health issue requiring high attention. The iodine balance study is an important method for exploring physiological iodine requirements. Few iodine balance studies have been conducted in the elderly. This study aimed to conduct an iodine balance study and provide information on the appropriate iodine intake level for elderly people.

ICD-10 classifications

Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulMalnutritionObesitySequelae of malnutrition and other nutritional deficienciesNutritional deficiency, unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06218043
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06218043 through Pure Global AI's free database. This phase not specified trial is sponsored by Wenxing Guo and is currently Recruiting. The study focuses on Nutrition, Healthy. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.